Literature DB >> 28194511

Should all septic patients be given systemic anticoagulation? No.

Tom van der Poll1, Steven M Opal2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28194511     DOI： 10.1007/s00134-016-4607-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

Review 1.  New anticoagulants: how to deal with treatment failure and bleeding complications.

Authors:  Rashid S Kazmi; Bashir A Lwaleed
Journal:  Br J Clin Pharmacol       Date:  2011-10       Impact factor: 4.335

2.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

3.  Drotrecogin alfa (activated) in adults with septic shock.

Authors:  V Marco Ranieri; B Taylor Thompson; Philip S Barie; Jean-François Dhainaut; Ivor S Douglas; Simon Finfer; Bengt Gårdlund; John C Marshall; Andrew Rhodes; Antonio Artigas; Didier Payen; Jyrki Tenhunen; Hussein R Al-Khalidi; Vivian Thompson; Jonathan Janes; William L Macias; Burkhard Vangerow; Mark D Williams
Journal:  N Engl J Med       Date:  2012-05-22       Impact factor: 91.245

Review 4.  Thrombosis as an intravascular effector of innate immunity.

Authors:  Bernd Engelmann; Steffen Massberg
Journal:  Nat Rev Immunol       Date:  2012-12-07       Impact factor: 53.106

5.  Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia.

Authors:  Bryce A Kerlin; S Betty Yan; Berend H Isermann; John T Brandt; Rashmi Sood; Bruce R Basson; David E Joyce; Hartmut Weiler; Jean-Francois Dhainaut
Journal:  Blood       Date:  2003-07-17       Impact factor: 22.113

6.  Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis.

Authors:  Lonneke A van Vught; Peter M C Klein Klouwenberg; Cristian Spitoni; Brendon P Scicluna; Maryse A Wiewel; Janneke Horn; Marcus J Schultz; Peter Nürnberg; Marc J M Bonten; Olaf L Cremer; Tom van der Poll
Journal:  JAMA       Date:  2016-04-12       Impact factor: 56.272

7.  Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis: a randomized controlled trial.

Authors:  Edward Abraham; Konrad Reinhart; Steven Opal; Ignace Demeyer; Christopher Doig; Angel López Rodriguez; Richard Beale; Petr Svoboda; Pierre Francois Laterre; Stuart Simon; Bruce Light; Herbert Spapen; Judy Stone; Allan Seibert; Claus Peckelsen; Cathy De Deyne; Russell Postier; Ville Pettilä; Charles L Sprung; Antonio Artigas; Sandra R Percell; Vincent Shu; Christian Zwingelstein; Jeffrey Tobias; Lona Poole; James C Stolzenbach; Abla A Creasey
Journal:  JAMA       Date:  2003-07-09       Impact factor: 56.272

Review 8.  Nosocomial infections in adult intensive-care units.

Authors:  Jean-Louis Vincent
Journal:  Lancet       Date:  2003-06-14       Impact factor: 79.321

9.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

10.  Bleeding and risk of death with hydroxyethyl starch in severe sepsis: post hoc analyses of a randomized clinical trial.

Authors:  Nicolai Haase; Jørn Wetterslev; Per Winkel; Anders Perner
Journal:  Intensive Care Med       Date:  2013-10-01       Impact factor: 17.440
View more
  9 in total

1.  Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease.

Authors:  Shiqi Yuan; Chong Chen; Fengshuo Xu; Didi Han; Rui Yang; Shuai Zheng; Mengmeng Qiao; Xiaxuan Huang; Jun Lyu
Journal:  Int J Clin Pract       Date:  2022-03-16       Impact factor: 3.149

2.  Fondaparinux pentasaccharide reduces sepsis coagulopathy and promotes survival in the baboon model of Escherichia coli sepsis.

Authors:  Ravi S Keshari; Robert Silasi; Narcis I Popescu; Constantin Georgescu; Hala Chaaban; Cristina Lupu; Owen J T McCarty; Charles T Esmon; Florea Lupu
Journal:  J Thromb Haemost       Date:  2019-10-16       Impact factor: 5.824

3.  The application of anticoagulant therapy to sepsis.

Authors:  Jecko Thachil; Toshiaki Iba
Journal:  J Intensive Care       Date:  2017-05-30

4.  Enzymatic Synthesis of Chondroitin Sulfate E to Attenuate Bacteria Lipopolysaccharide-Induced Organ Damage.

Authors:  Jine Li; Erica M Sparkenbaugh; Guowei Su; Fuming Zhang; Yongmei Xu; Ke Xia; Pen He; Sultan Baytas; Shannon Pechauer; Anand Padmanabhan; Robert J Linhardt; Rafal Pawlinski; Jian Liu
Journal:  ACS Cent Sci       Date:  2020-07-01       Impact factor: 14.553

5.  Coagulative biomarkers on admission to the ICU predict acute kidney injury and mortality in patients with septic shock caused by intra-abdominal infection.

Authors:  Zhipeng Xu; Baoli Cheng; Shuiqiao Fu; Xu Liu; Guohao Xie; Zhongwang Li; Yun Ji; Qinghui Fu; Zhinan Xu; Xiangming Fang
Journal:  Infect Drug Resist       Date:  2019-09-04       Impact factor: 4.003

Review 6.  Venous Thromboembolism in Sepsis: From Bench to Bedside.

Authors:  Eleonora Galli; Elena Maggio; Fulvio Pomero
Journal:  Biomedicines       Date:  2022-07-08

Review 7.  Immunohaemostasis: a new view on haemostasis during sepsis.

Authors:  Xavier Delabranche; Julie Helms; Ferhat Meziani
Journal:  Ann Intensive Care       Date:  2017-12-02       Impact factor: 6.925

8.  Early Changes in the Sequential Organ Failure Assessment Score Among Patients With Sepsis-Induced Disseminated Intravascular Coagulation.

Authors:  Katsunori Mochizuki; Kotaro Mori; Yuta Nakamura; Ryo Uchimido; Hiroshi Kamijo; Kanako Takeshige; Kenichi Nitta; Hiroshi Imamura
Journal:  Clin Appl Thromb Hemost       Date:  2018-11-28       Impact factor: 2.389

9.  Global hemostatic status in patients with acute-on-chronic liver failure and septics without underlying liver disease.

Authors:  Ton Lisman; Bethlehem Arefaine; Jelle Adelmeijer; Ane Zamalloa; Eleanor Corcoran; John G Smith; William Bernal; Vishal C Patel
Journal:  J Thromb Haemost       Date:  2020-11-29       Impact factor: 5.824
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.